REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
54,662,151
Share change
+833,618
Total reported value
$7,739,525,912
Put/Call ratio
87%
Price per share
$141.46
Number of holders
441
Value change
+$95,572,264
Number of buys
218
Number of sells
214

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2023

As of 30 Jun 2023 REPLIGEN CORP - COMMON STOCK (RGEN) had 441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 54,662,151 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, BROWN CAPITAL MANAGEMENT LLC, Artisan Partners Limited Partnership, WELLINGTON MANAGEMENT GROUP LLP, and AMERIPRISE FINANCIAL INC.
This table shows 441 institutional shareholders of the security as of 30 Jun 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.